We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $179M
1-Year Est. Return 63.61%
This Fund
S&P 500
This Quarter Est. Return
+26.75%
1 Year Est. Return
+63.61%
3 Year Est. Return
+260.15%
5 Year Est. Return
+585.87%
10 Year Est. Return
+8,784.38%
AUM
$191M
AUM Growth
+$38M
Cap. Flow
+$5.32M
Cap. Flow %
2.78%
Top 10 Hldgs %
83.76%
Holding
42
New
3
Increased
4
Reduced
1
Closed

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$888K

Sector Composition

Rank Sector Weight
1 Healthcare 81.9%
2 Miscellaneous 6%
3 Materials 4.88%
4 Technology 2.41%
5 Financials 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$83.2M 43.44%
856,844
APLT
2
DELISTED
Applied Therapeutics
APLT
$21.4M 11.2%
1,032,123
+6,659
+0.6% +$126K
ENTX icon
3
Entera Bio
ENTX
$507M
$14.9M 7.76%
2,484,275
+692,912
+39% +$2.56M
CRBP icon
4
Corbus Pharmaceuticals
CRBP
$201M
$9.23M 4.82%
168,196
ALDX icon
5
Aldeyra Therapeutics
ALDX
$90.5M
$6.45M 3.37%
569,405
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$5.92M 3.09%
23,141
ABEO icon
7
Abeona Therapeutics
ABEO
$341M
$4.46M 2.33%
114,391
ANVS icon
8
Annovis Bio
ANVS
$57.1M
$3.36M 1.75%
+39,210
New +$1.81M
LUMN icon
9
Lumen
LUMN
$6.91B
$2.99M 1.56%
220,000
BX icon
10
Blackstone
BX
$101B
$2.91M 1.52%
30,000
-10,000
-25% -$888K
XCUR icon
11
Exicure
XCUR
$9.3M
$1.92M 1%
8,519
DOW icon
12
Dow Inc
DOW
$21.4B
$1.9M 0.99%
30,000
CTVA icon
13
Corteva
CTVA
$56.9B
$1.33M 0.7%
30,000
ANET icon
14
Arista Networks
ANET
$251B
$1.25M 0.65%
55,200
CVS icon
15
CVS Health
CVS
$123B
$1.21M 0.63%
14,500
DD icon
16
DuPont de Nemours
DD
$17.8B
$1.16M 0.61%
11,950
AMD icon
17
Advanced Micro Devices
AMD
$834B
$1.16M 0.61%
+12,350
New +$998K
V icon
18
Visa
V
$688B
$1.13M 0.59%
4,850
ALT icon
19
Altimmune
ALT
$656M
$1.11M 0.58%
50,000
VMW
20
DELISTED
VMware, Inc
VMW
$1.11M 0.58%
6,950
BAH icon
21
Booz Allen Hamilton
BAH
$8.68B
$1.11M 0.58%
13,000
GLW icon
22
Corning
GLW
$145B
$1.09M 0.57%
26,600
MO icon
23
Altria Group
MO
$114B
$1.08M 0.57%
22,700
TMO icon
24
Thermo Fisher Scientific
TMO
$224B
$1.06M 0.55%
2,100
SNGX icon
25
Soligenix
SNGX
$8.3M
$874K 0.46%
3,286

Similar funds

Knoll Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Knoll Capital Management held 42 positions worth $191M, up 25% from $153M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Knoll Capital Management's Q2 2021 filing shows 3 new, 4 increased and 1 reduced positions. Its largest new stake was Annovis Bio: 39,210 shares worth $3.36M. The largest sale was Blackstone, an estimated $888K.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Materials.

  • Knoll Capital Management's largest Q2 2021 buy was Annovis Bio: 39,210 shares worth $3.36M.
  • Knoll Capital Management added most to Entera Bio in Q2 2021, an estimated $2.56M increase.
  • Knoll Capital Management's biggest Q2 2021 reduction was Blackstone, cutting an estimated $888K.
  • Knoll Capital Management's ten largest holdings make up 84% of its $191M portfolio in Q2 2021.
  • Knoll Capital Management opened 3 new positions and closed 0 in Q2 2021.
  • Knoll Capital Management's portfolio value rose 25% quarter-over-quarter to $191M.

Based on Knoll Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.